Fresh tracks therapeutics inc

0.90 USD
-0.03 (-3.24%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fresh tracks therapeutics inc stock is down -2.72% since 30 days ago. The next earnings date is Jul 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 31 June’s closed higher than May.

About Fresh tracks therapeutics inc

Brickell Biotech, Inc. engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofironium bromide, which has completed Phase III clinical trials for the. treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor, and BBI10, a covalent stimulator of interferon genes inhibitor.